Search research articles
Contact Us
Filters
Showing results (51-60 of 229) with videos related to
Page
of 23
Sort By:
Journal of Health Services Research & Policy
|
January 25, 2007
The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm
Helen Campbell, Andrew Briggs, Martin Buxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 5, 2013
The "hazards" of extrapolating survival curves
Charlotte Davies, Andrew Briggs, Paula Lorgelly, et al.
Plos One
|
March 10, 2015
Hospital expenditure at the end-of-life: what are the impacts of health status and health risks?
Claudia Geue, Paula Lorgelly, James Lewsey, et al.
Pharmacoeconomics
|
November 6, 2022
Health Economic Evaluation Using Markov Models in R for Microsoft Excel Users: A Tutorial
Nathan Green, Felicity Lamrock, Nichola Naylor, et al.
European Heart Journal
|
December 14, 2017
'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
Lieven Annemans, Chris J Packard, Andrew Briggs, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 16, 2016
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer
Gabriel Tremblay, Christopher Livings, Lydia Crowe, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 3, 2022
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory setting
Nick Jovanoski, Andreas Kuznik, Ursula Becker, et al.
Journal of Patient-Reported Outcomes
|
January 13, 2021
The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data
Andrew Briggs, Shuaib Nasser, Eva Hammerby, et al.
Journal of Medical Economics
|
July 30, 2019
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial
Katherine Dick, Andrew Briggs, Robert Ohsfeldt, et al.
Transplantation
|
May 9, 2009
Acute rejection and chronic nephropathy: a systematic review of the literature
Olivia Wu, Adrian R Levy, Andrew Briggs, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 229) with videos related to
Sort By:
Page
of 23
Journal of Health Services Research & Policy
|
January 25, 2007
The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm
Helen Campbell, Andrew Briggs, Martin Buxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 5, 2013
The "hazards" of extrapolating survival curves
Charlotte Davies, Andrew Briggs, Paula Lorgelly, et al.
Plos One
|
March 10, 2015
Hospital expenditure at the end-of-life: what are the impacts of health status and health risks?
Claudia Geue, Paula Lorgelly, James Lewsey, et al.
Pharmacoeconomics
|
November 6, 2022
Health Economic Evaluation Using Markov Models in R for Microsoft Excel Users: A Tutorial
Nathan Green, Felicity Lamrock, Nichola Naylor, et al.
European Heart Journal
|
December 14, 2017
'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
Lieven Annemans, Chris J Packard, Andrew Briggs, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 16, 2016
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer
Gabriel Tremblay, Christopher Livings, Lydia Crowe, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 3, 2022
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory setting
Nick Jovanoski, Andreas Kuznik, Ursula Becker, et al.
Journal of Patient-Reported Outcomes
|
January 13, 2021
The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data
Andrew Briggs, Shuaib Nasser, Eva Hammerby, et al.
Journal of Medical Economics
|
July 30, 2019
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial
Katherine Dick, Andrew Briggs, Robert Ohsfeldt, et al.
Transplantation
|
May 9, 2009
Acute rejection and chronic nephropathy: a systematic review of the literature
Olivia Wu, Adrian R Levy, Andrew Briggs, et al.
Page
of 23